Changes in Breast 3D Ultrasound Measurements Using Toremifene

Satakunta Central Hospital

Status and phase: Completed; Phase 3

Conditions: Circulatory; Change

Treatments: Drug: Toremifene

Study type: Interventional

Funder types: Other

Identifiers

NCT01417754

Tore3D

Details and patient eligibility

About

To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.

Full description

20 women were participated to this trial.

Enrollment: 20 patients

Sex: Female

Ages: 25 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age 25-45 healthy person
• regular menstrual cycles
• safe contraception(for example sterilization or condom)

Exclusion criteria

• gynecological or other type of cancer
• hormonal contraception
• pregnancy

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Toremifene

Other group

Treatment:

Drug: Toremifene